Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $12.20 Price Valuation
Share
Why It Matters
An analyst group set a price target of $12.20 for Bone Biologics. When experts publish targets, watch how the stock moves and whether the company hits its goals.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.